Long-Term Tolerability and Efficacy of Golimumab in Active Nonradiographic Axial Spondyloarthritis: Results from the Open-Label Extension of a Randomized, Double-Blind Study

被引：0
|
作者：
van der Heijde, Desiree [1 ]
Dougados, Maxime [2 ]
Maksymowych, Walter [3 ]
Bergman, Gina [4 ]
Curtis, Sean P. [4 ]
Tzontcheva, Anjela [4 ]
Philip, George [4 ]
Huyck, Susan [4 ]
Sieper, Joachim [5 ]
机构：
[1] Leiden Univ, Med Ctr, Leiden, Netherlands
[2] Paris Descartes Univ, Paris, France
[3] Univ Alberta, Edmonton, AB, Canada
[4] Merck & Co Inc, Kenilworth, NJ USA
[5] Univ Clin Benjamin Franklin, Berlin, Germany
来源：
ARTHRITIS & RHEUMATOLOGY | 2015年 / 67卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2854
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Long-Term Efficacy, Safety, and Pharmacokinetics of Drisapersen in Duchenne Muscular Dystrophy: Results from an Open-Label Extension Study
    Goemans, Nathalie M.
    Tulinius, Mar
    van den Hauwe, Marleen
    Kroksmark, Anna-Karin
    Buyse, Gunnar
    Wilson, Rosamund J.
    van Deutekom, Judith C.
    de Kimpe, Sjef J.
    Lourbakos, Afrodite
    Campion, Giles
    PLOS ONE, 2016, 11 (09):
  • [42] Long-term safety and efficacy of ozanimod in relapsing multiple sclerosis: results from the DAYBREAK open-label extension study
    Steinman, L.
    Comi, G.
    Bar-Or, A.
    Selmaj, K. W.
    Arnold, D. L.
    Hartung, H. -P.
    Montalban, X.
    Havrdova, E. K.
    Sheffield, J. K.
    Minton, N.
    Janjua, A.
    Huang, V.
    Silva, D.
    Kappos, L.
    Cohen, J. A.
    Cree, B. A. C.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 548 - 549
  • [43] Long-term efficacy and safery of switching from Ustekinumab to Risankizuman: results from the open-label extension LIMMitless
    Strober, Bruce
    Eyerich, Killian
    Hong, H. Chih-Ho
    Zeng, Jiewei
    Valdecantos, Wendell C.
    Valdes, Joaquin
    Bachelez, Herve
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2020, 18 : 19 - 19
  • [44] Adjunctive zonisamide therapy in the long-term treatment of children with partial epilepsy: Results of an open-label extension study of a phase III, randomized, double-blind, placebo-controlled trial
    Guerrini, Renzo
    Rosati, Anna
    Bradshaw, Kate
    Giorgi, Luigi
    EPILEPSIA, 2014, 55 (04) : 568 - 578
  • [45] LONG-TERM TREATMENT WITH LURASIDONE IN SCHIZOPHRENIA: RESULTS OF AN 8-WEEK DOUBLE-BLIND ACUTE STUDY FOLLOWED BY A 44-WEEK OPEN-LABEL EXTENSION
    Kato, Masaki
    Ogasa, Masaaki
    Ogo, Hiroki
    Ishige, Yoko
    Sawabe, Hiroshi
    Siu, Cynthia
    Loebel, Antony
    SCHIZOPHRENIA RESEARCH, 2012, 136 : S351 - S352
  • [46] Long-term safety and tolerability of nintedanib in patients with idiopathic pulmonary fibrosis: results from the open-label extension study, INPULSIS-ON
    Crestani, Bruno
    Huggins, John T.
    Kaye, Mitchell
    Costabel, Ulrich
    Glaspole, Ian
    Ogura, Takashi
    Song, Jin Woo
    Stansen, Wibke
    Quaresma, Manuel
    Stowasser, Susanne
    Kreuter, Michael
    LANCET RESPIRATORY MEDICINE, 2019, 7 (01): : 60 - 68
  • [47] Long-term efficacy and safety of omalizumab for nasal polyposis in an open-label extension study
    Gevaert, Philippe
    Saenz, Rebecca
    Corren, Jonathan
    Han, Joseph K.
    Mullol, Joaquim
    Lee, Stella E.
    Ow, Randall A.
    Zhao, Rui
    Howard, Monet
    Wong, Kit
    Islam, Lutaf
    Ligueros-Saylan, Monica
    Omachi, Theodore A.
    Bachert, Claus
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (03) : 957 - +
  • [48] LONG-TERM SAFETY, IMMUNOGENICITY AND EFFICACY IN RANDOMIZED, DOUBLE-BLIND, AND OPEN-LABEL EXTENSION STUDIES COMPARING FKB327, AN ADALIMUMAB BIOSIMILAR, WITH THE ADALIMUMAB REFERENCE PRODUCT IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS
    Alten, Rieke
    Genovese, Mark C.
    Arai
    Muniz, Rafael
    Kellner, Herbert
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1135 - 1135
  • [49] LINACLOTIDE IS EFFECTIVE AND SAFE FOR PATIENTS WITH CHRONIC CONSTIPATION IN JAPAN: A PHASE III RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY WITH A LONG-TERM OPEN-LABEL EXTENSION STUDY
    Fukudo, Shin
    Miwa, Hiroto
    Nakajima, Atsushi
    Kinoshita, Yoshikazu
    Kosako, Masanori
    Hayashi, Kenta
    Akiho, Hikaru
    Kuroishi, Kentarou
    Johnston, Jeffrey M.
    Currie, Mark
    Ohkusa, Toshifumi
    GASTROENTEROLOGY, 2018, 154 (06) : S973 - S974
  • [50] Long-term treatment with zonisamide: Results of a 2 year open-label extension study
    Wroe, S.
    Duncan, R.
    EPILEPSIA, 2006, 47 : 138 - 138
12345